ScoreCardiology

Stroke risk in atrial fibrillation (CHA2DS2-VASc)

Estimates thromboembolic risk in non-valvular atrial fibrillation to guide anticoagulation.

Updated 5 November 2026

When to use it

Atrial fibrillation or flutter without moderate-severe mitral stenosis or a mechanical valve, at diagnosis and whenever the clinical picture changes.

What it needs

  • Heart failure or moderate-severe left ventricular dysfunctionYes or no
  • HypertensionYes or no
  • AgeOptions: < 65 years · 65–74 years · ≥ 75 years
  • Diabetes mellitusYes or no
  • Prior stroke, TIA or systemic embolismYes or no
  • Vascular disease (prior MI, peripheral artery disease or aortic plaque)Yes or no
  • SexOptions: Male · Female

The points for each answer and the automatic total are in the app.

How to interpret it

The result is read in its clinical context; the app shows it with its units and warnings.

In the app it also calculates: Factors excluding sex (CHA2DS2-VA).

Practical tip

Female sex is a modifier, not a risk factor on its own: a woman with no other factors is low risk. The 2024 ESC guidelines use CHA2DS2-VA, without the sex point.

3 more practical tips in the app.

Reference

A support tool for healthcare professionals: it guides and does not replace clinical judgement.

Back to top